2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · 174 citations · Paul Dellaripa
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Arthritis & rheumatology (Hoboken, N.J.) · 2024 · 132 citations · Paul Dellaripa
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
The Lancet. Respiratory medicine · 2023 · 186 citations · Paul Dellaripa
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Arthritis care & research · 2024 · 111 citations · Paul Dellaripa
Granzyme K+ CD8 T cells form a core population in inflamed human tissue.
Science translational medicine · 2022 · 251 citations · Elena Massarotti
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
Arthritis care & research · 2024 · 58 citations · Paul Dellaripa
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial.
Arthritis & rheumatology (Hoboken, N.J.) · 2022 · 104 citations · Paul Dellaripa
Interferon subverts an AHR-JUN axis to promote CXCL13+ T cells in lupus.
Nature · 2024 · 84 citations · Elena Massarotti